Hzj-jie/build-a-compiler ...

This week, updates related to "certificates" were released for Java, Node.js, Go, and Python respectively. While they may appear to be separate issues, they all stem from the same incident. Eight inte ...

Cheap labor and global supply chains are among the obstacles to President Trump’s plan to bring generic drug manufacturing back home. Credit...Video by Harsha Vadlamani Supported by By Alex Travelli ...

Illinois residents who purchased a generic drug between May 2009 and December 2019 could be eligible for payouts as part of a series of allegations that drug companies conspired to manipulate prices.

Sandoz Group SDZ2.55%increase; up pointing triangle said it received approval from Canada’s drug regulator for its generic version of Novo Nordisk’s NOVO.B-1.46%decrease; down pointing triangle ...

Wilderness Bound is out now in Minecraft Java Edition! Pack your supplies and set off on an expedition into the dappled forest where the trails end and adventure begins. Seek out abandoned camps, ...

Par Health has launched the first generic formulation of Janumet XR in 3 extended-release dosage strengths, offering a lower-cost alternative for glycemic control. Par Health announced the ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Trump plans tariffs of up to 200% on imported generic drugs after a two-year grace period aimed at encouraging U.S. manufacturing. But thin profit margins make tariffs harder to absorb than for ...

President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

The Hikma Court correctly held that a generic manufacturer should not be liable for induced patent infringement if it carves patented uses out of its label. FDA can navigate Hikma’s aftermath without ...